The effect of socio-economic deprivation on severity of glaucoma at presentation

Ng, Wai Siene; Agarwal, Pankaj; Sidiki, Sikander S; McKay, Lucy; Townend, John; Azuara‐Blanco, Augusto

doi:10.1136/bjo.2008.153312

Cited by 111 publications

(99 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…24 A number of studies have also shown that age is associated with severity of glaucoma at presentation. 22,25,26 This is of additional concern for the elderly population with undiagnosed disease, as age and severity at presentation are both risk factors for development of blindness in glaucoma. [27][28][29][30] Other population-based studies that have looked at more focused geographic or demographic population segments in the US and globally have also reported high proportions of undiagnosed and untreated glaucoma.…”

Section: We Found That Approximately 24 Million People Inmentioning

confidence: 98%

Burden of Undetected and Untreated Glaucoma in the United States

Shaikh

Coleman

2014

American Journal of Ophthalmology

125

View full text Add to dashboard Cite

Section: We Found That Approximately 24 Million People Inmentioning

confidence: 98%

Burden of Undetected and Untreated Glaucoma in the United States

Shaikh

Coleman

2014

American Journal of Ophthalmology

125

View full text Add to dashboard Cite

“…Worryingly this 'missing' group is more likely to include socio-economically deprived people with no family history of glaucoma and people who do not visit their optometrist. 9,10 The spontaneous case-finding by the community optometrist is after all the main way the disease is detected in a timely manner in the UK. On the whole, UK optometrists do this well.…”

Section: The Burden Of Glaucomamentioning

confidence: 99%

A view on glaucoma—are we seeing it clearly?

Crabb

2015

Eye

View full text Add to dashboard Cite

Successful clinical management of glaucoma should not simply be about control of intraocular pressure, but must equate to correct decisions about intensifying treatment when patients are at risk of developing 'visual disability'. Yet little is known about what visual field defects, at different stages of glaucoma, specifically affect patients' abilities to perform everyday visual tasks. One way to do this is to measure patient performance in tasks in a lab setting. Another way is to ask patients themselves. The latter can be revealing and demystify views about how patients perceive the world. This short commentary highlights some of the current research in this area.

show abstract

“…Between 10-33% of glaucoma patients present with advanced glaucoma, [1][2][3][4][5][6] this is a risk factor for blindness. 3,5,[7][8][9] Reduction in intraocular pressure is the only treatable risk factor for glaucoma and may be achieved by either medical or surgical intervention.…”

Section: Introductionmentioning

confidence: 99%

The willingness of patients presenting with advanced glaucoma to participate in a trial comparing primary medical vs primary surgical treatment

Leighton

Lonsdale

Tildsley

et al. 2011

Eye

View full text Add to dashboard Cite

Aim The aim of this study is to examine the attitudes of patients, who presented with advanced glaucoma in at least one eye, to participation in a randomised prospective trial comparing primary medical treatment with primary surgical treatment for advanced glaucoma. Methods Patients who had presented with advanced glaucoma (415 dB loss mean deviation on Humphrey visual field testing) in at least one eye were asked to participate. Five focus groups comprising of 4-8 patients and consisting of 29 patients in total were undertaken. The group interviews were conducted by two experienced qualitative researchers, an ophthalmic clinician was present to clarify technical issues. The focus group discussions were taped and transcribed in full, and analysed through a process of familiarisation, open (inductive) coding, theme generation, theme refinement, and thematic mapping. Results Three overarching themes were identified: (1) the extent of patients' knowledge, (2) anxieties about surgery, and (3) concerns about compromised care due to trial involvement; these themes were further classified into eight sub-themes. Conclusions Patients' willingness to participate in randomised clinical studies is significantly connected to their level of comprehension and insight about the medical condition, its treatment, and the research process; misunderstandings about any of these aspects may act as a significant barrier to trial recruitment. Recruitment rates for future randomised trials may be enhanced by ensuring that patients have full and accurate information about the treatment alternatives, and that uncertainty exists for best patient outcomes between treatment options, and reassuring potential participants that the research process, in particular randomisation, will not compromise clinical care.

show abstract

The effect of socio-economic deprivation on severity of glaucoma at presentation

Cited by 111 publications

References 27 publications

Burden of Undetected and Untreated Glaucoma in the United States

Burden of Undetected and Untreated Glaucoma in the United States

A view on glaucoma—are we seeing it clearly?

The willingness of patients presenting with advanced glaucoma to participate in a trial comparing primary medical vs primary surgical treatment

Contact Info

Product

Resources

About